Seeing Is Believing

Currently out of the existing stock ratings of Dan Leonard, 162 are a BUY (62.79%), 78 are a HOLD (30.23%), 18 are a SELL (6.98%).
Analyst Dan Leonard, currently employed at UBS, carries an average stock price target met ratio of 69.06% that have a potential upside of 19.61% achieved within 259 days. Previously, Dan Leonard worked at RBC.
Dan Leonard’s has documented 535 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on A, Agilent Technologies.
Analyst best performing recommendations are on STVN (STEVANATO GROUP SPA).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 2/25/2026. The price target of $175 was fulfilled within 1 day with a profit of $7.44 (4.44%) receiving and performance score of 44.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Sep-2026
$165
$20.25 (13.99%)
$185
Buy Since 22-Aug-2024
$190
$45.25 (31.26%)
$185
15 days ago
(27-Aug-2026)
17/24 (70.83%)
$32.31 (20.49%)
77
Buy Since 30-May-2024
$180
$35.25 (24.35%)
$151
15 days ago
(27-Aug-2026)
13/16 (81.25%)
$22.31 (14.15%)
104
Buy Since 09-Oct-2025
$190
$45.25 (31.26%)
$180
15 days ago
(27-Aug-2026)
0/3 (0%)
$32.31 (20.49%)
Buy Since 06-Apr-2026
$172
$27.25 (18.83%)
$148
15 days ago
(27-Aug-2026)
9/11 (81.82%)
$14.31 (9.07%)
38
Which stock is Dan Leonard most bullish on?
Which stock is Dan Leonard most reserved on?
What Year was the first public recommendation made by Dan Leonard?